UCB’s Vimpat NDA Seeks Indications For Epileptic Seizures, Diabetic Pain

Belgian firm has an anticipated July 2008 user fee date for lacosamide, which was submitted as a single NDA with two indications, for partial onset seizures in epilepsy and diabetic neuropathic pain.